<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-4X56MSMF/973f68a8-4dc2-4bf7-96bb-997b2edf107f/HTML"><dcterms:extent>37 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-4X56MSMF/4138ed63-b5c7-4c1d-a62d-7f335cbb74c0/PDF"><dcterms:extent>120 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-4X56MSMF/02220e2a-d80f-4e0c-b938-24cf65a73a12/TEXT"><dcterms:extent>33 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-4X56MSMF"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2009</dcterms:issued><dc:creator>Kersnik, Janko</dc:creator><dc:creator>Petek Šter, Marija</dc:creator><dc:format xml:lang="sl">številka:6/7</dc:format><dc:format xml:lang="sl">letnik:78</dc:format><dc:format xml:lang="sl">str. 295-301</dc:format><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID:25971929</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-4X56MSMF</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">Antihipertenzivi</dc:subject><dc:subject xml:lang="en">Antihypertensive Agents</dc:subject><dc:subject xml:lang="sl">arterijska hipertenzija</dc:subject><dc:subject xml:lang="en">Blood Pressure Monitoring, Ambulatory</dc:subject><dc:subject xml:lang="en">Drug Therapy</dc:subject><dc:subject xml:lang="sl">Družinska medicina</dc:subject><dc:subject xml:lang="en">Family Practice</dc:subject><dc:subject xml:lang="sl">Hipertenzija</dc:subject><dc:subject xml:lang="en">Hypertension</dc:subject><dc:subject xml:lang="sl">Krvni pritisk, ambulantno merjenje</dc:subject><dc:subject xml:lang="sl">krvni tlak</dc:subject><dc:subject xml:lang="sl">merjenje</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Vpliv 24-urnega neinvazivnega merjenja krvnega tlaka na obravnavo bolnikov z arterijsko hipertenzijo v družinski medicini| Impact of 24-hours non-invasive blood pressure monitoring on hypertension management in general practice|</dc:title><dc:description xml:lang="sl">Background Ambulatory blood pressure monitoring (ABPM) gives important additional information to office blood-pressure measurements in diagnostic andtreatment of patients with high blood pressure. The aim of our survey is tofind out the impact of ABPM on management of arterial hypertension in primary care.Patients and We included 339 consecutive patients with uncontrolled arterial hypertension, treated with methods at least two different antihypertensive drug classes in 38 general practitionerćs offices in Slovenia. We randomly divided patients into the test (ABPM) and the controlgroup (office measurements only). After 12 weeks we assessed the impactof ABPM on management of arterial hypertension. results We analysed dataof 339 patients: 160 in the testing and 179 in the control group, aged from 34 to 80 years (mean 61.4 years, SD 9.8 years) with mean systolic blood pressure 159.2 (SD 12.5) mm Hg and mean diastolic blood pressure 92.1 (SD 8.7)mm Hg. 45 (28.1 %) of patients after ABPM have controlled blood pressure. Possibility for controlled blood pressure is higher in female (OR = 5.445, 95 % CI: 2.16-13.76) and patients with lower mean office blood pressure (OR = 0.931, 95 % CI: 0.84-0.97). Performance of ABPM did not have impact on the number of hypertension related office visits (1.6 in tested vs. 1.7 in controlgroup, p = 0.306). Patients in the testing group less often underwent changes of antihypertensive drug therapy (52.5 % vs. 66.5 % in the control group, p = 0.009). Conclusions White coat effect is common in patients on combined antihypertensive therapy in primary care. APBM did not reduce the number of office visits, but reduced the probability of antihypertensive drug changes</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-4X56MSMF"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-4X56MSMF" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-4X56MSMF/4138ed63-b5c7-4c1d-a62d-7f335cbb74c0/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-4X56MSMF/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-4X56MSMF" /></ore:Aggregation></rdf:RDF>